| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.700 | None | 0.899 | 5 | 0 | 2004 | 2019 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.500 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.700 | None | 0.975 | 4 | 0 | 1989 | 2020 | ||||||||
|
PR/SET domain 1 | 0.538 | 0.731 | 0.96 |
|
disease | 0.330 | None | 0.833 | 3 | 0 | 2009 | 2019 | ||||||||
|
C-C motif chemokine ligand 21 | 0.502 | 0.769 | 3.6E-02 |
|
disease | 0.400 | None | 0.857 | 3 | 0 | 2003 | 2019 | ||||||||
|
REL proto-oncogene, NF-kB subunit | 0.579 | 0.692 | 1.00 |
|
disease | 0.460 | None | 0.909 | 3 | 0 | 2009 | 2019 | ||||||||
|
protein kinase C theta | 0.636 | 0.654 | 0.30 |
|
disease | 0.340 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 3 | 0 | 1992 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.976 | 3 | 0 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 3 | 0 | 1989 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.340 | None | 0.714 | 3 | 0 | 2000 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.848 | 3 | 0 | 2002 | 2019 | ||||||||
|
CD28 molecule | 0.436 | 0.885 | 0.36 |
|
disease | 0.500 | None | 1.000 | 3 | 0 | 1996 | 2018 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
disease | 0.500 | None | 1.000 | 3 | 0 | 2001 | 2019 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.500 | None | 0.889 | 2 | 0 | 2000 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.968 | 2 | 0 | 1990 | 2020 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.500 | None | 0.971 | 2 | 0 | 2001 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.976 | 2 | 0 | 1988 | 2020 | ||||||||
|
interleukin 2 receptor subunit beta | 0.491 | 0.846 | 0.29 |
|
disease | 0.470 | None | 0.909 | 2 | 0 | 1992 | 2019 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2004 | 2007 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.400 | None | 0.947 | 2 | 0 | 1992 | 2020 | ||||||||
|
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | 0.729 | 0.346 | 0.17 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
recombination signal binding protein for immunoglobulin kappa J region | 0.518 | 0.808 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2016 | ||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.500 | None | 0.906 | 2 | 0 | 2006 | 2019 | ||||||||
|
AF4/FMR2 family member 3 | 0.623 | 0.692 | 1.00 |
|
disease | 0.460 | None | 1.000 | 2 | 0 | 2009 | 2016 |